Lipid Forum-4 ASCVD治疗新进展
|
10:00-12:00 307 |
|---|
| 主持 Moderators | 李建平 Jianping LI, 傅国胜 Guosheng FU | ||
| 特邀嘉宾 Invited Guests | 王建安 Jianan WANG | ||
| 讨论嘉宾 Discussants | 叶涛 Tao YE, 董樑 Liang DONG, 胡涛 Tao HU | ||
|
10:00-10:05 |
开场致辞 Opening Remarks |
||
|
10:05-10:35 |
《高血压患者靶器官动态评估与长程管理专家共识》解读 Interpretation of the Expert Consensus on Ongoing Target Organ Evaluation and Longitudinal Management of Hypertension |
陶军 Jun TAO | |
|
10:35-11:05 |
双料印证，降脂破局：从RCT到RWS的双料冠军 Bridging RCT to RWS: The Validated Efficacy of a Leading Lipid-Lowering Therapy |
张毅 Yi ZHANG | |
|
11:05-11:25 |
从“强效降脂”到“持久达标”： ACS到CCS血脂管理新策略 From Potent Reduction to Sustained Goals: Novel Lipid Management Strategies Across the ACS-CCS Spectrum |
曹乾 Qian CAO | |
|
11:25-11:55 |
大咖论道 Expert Discussion |
||
|
11:55-12:00 |
总结 Discussion |
||
Coronary Physiology Symposium
|
13:30-15:30 307 |
|---|
| 主持 Moderators | 钱菊英 Juying QIAN, 刘斌 Bin LIU, 杨伟宪 Weixian YANG, 高海 Hai GAO | ||
| 讨论嘉宾 Discussants | 丁风华 Fenghua DING, 郭宁 Ning GUO, 金元哲 Yuanzhe JIN, 王敬萍 Jingping WANG | ||
|
13:30-13:35 |
嘉宾致辞 Guest Speech |
王建安 Jianan WANG | |
|
13:35-13:55 |
“融合无界”冠脉影像新功能及技术介绍 “Fusion Pilot” Coronary Imaging New Function & Technology Introduction |
涂圣贤 Shengxian TU | |
|
13:55-14:10 |
“融合无界”功能及影像技术——多模态QFR发布仪式 “Boundless Integration” Function and Imaging Technology — Multimodal QFR Launch Ceremony |
||
|
14:10-14:30 |
“融合无界”新技术冠脉复杂病变临床应用 Clinical Application of the “Boundless Integration” New Technology in Complex Coronary Lesions |
蒋峻 Jun JIANG | |
|
14:30-14:50 |
“融合无界”新技术冠脉分叉病变临床应用 Clinical Application of the “Boundless Integration” New Technology in Coronary Bifurcation Lesions |
宋雷 Lei SONG | |
|
14:50-15:10 |
“融合无界”新技术冠脉CTO病变临床应用 Clinical Application of the “Boundless Integration” New Technology in Coronary CTO Lesions |
鄢华 Hua YAN | |
|
15:10-15:30 |
讨论 Discussion |
||
Metabolic & CVD Forum-3
|
15:30-17:30 307 |
|---|
| 主持 Moderators | 蒋峻 Jun JIANG, 何红 Hong HE | ||
|
15:30-15:50 |
高血压合并肥胖患者，长期体重管理势在必行 Long-Term Weight Management is Imperative for Hypertensive Patients with Obesity |
高秀芳 Xiufang GAO | |
|
15:50-16:10 |
肥胖合并ASCVD减重助益疾病综合管理 Weight Management Improves Clinical Outcome of Obesity &ASCVD Comorbidity |
何红 Hong HE | |
|
16:10-16:30 |
穆峰达在T2DM多维度血糖管理中的优势 The superiority of Mounjaro in T2DM Management |
郑超 Chao ZHENG | |
|
16:30-16:50 |
从药物机制出发谈替尔泊肽消除异位脂肪沉积 Discussion on Tirzepatide Eliminating Ectopic Fat Deposition from the Perspective of Drug Mechanism |
刘治军 Zhijun LIU | |
|
16:50-17:10 |
成人肥胖合并血脂异常病例管理 Case Sharing |
杨莹 Ying YANG | |
|
17:10-17:30 |
讨论 Discussion |
||